LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Executives

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
123
LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) Executives Outline Positive PEA Results Plus Company’s Next Steps to Production in Investor Webinar

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising.

- Canadian near-term gold producer LaFleur Minerals recently released the results of a Preliminary Economic Assessment (“PEA”) outlining a capital efficient project with robust economic returns
- LaFleur executives Kal Malhi (Chairman) and Paul Ténière (CEO and Director) participated in a March 24 webinar where they discussed the positive PEA results with investors as well as outlining some of the company’s next steps
- LaFleur’s strategy is based on a low CapEx mine-to-mill project, which includes a wholly owned and permitted gold mill approaching restart readiness, a tailings pond and a gold deposit that has undergone advanced exploration outlining expansion and scalability
- The mill is expected to begin processing material in the spring, thanks partly to the success of prior capital raises, with another anticipated in April or May

LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) executives promoted the company’s expectations for a straightforward path to profitability, backed by the results of a recently completed Preliminary Economic Assessment (“PEA”), during a March 24 webinar with investors.

Board of Directors Chairman Kal Malhi pointed out the advantages of LaFleur’s three-tiered economic model, which includes the interconnected relationship between the company’s Beacon Gold Mill, the tailings pond at the mill, and the Swanson Gold Deposit all located within close proximity to each other in the prolific Tier‑1 Abitibi Greenstone Belt of Eastern Canada.

“That PEA shows healthy economics,” Malhi said before inviting questions from webinar participants. “We’re a junior gold company but we’re very unique in having those three assets. … Our Beacon Mill is 20 minutes out of the town Val d’Or, which is the best mining town in Canada. And the Swanson Project isn’t too far, so our staff could live in Val d’Or, go to work every day. This isn’t a project where we’re flying in material and staff and building camps. So with the price of gold where it is, having the mill ready to go, that’s a unique investment opportunity, I think.”

CEO and Director Paul Ténière noted that the PEA’s very conservative base case metric is established on a market in which gold would be trading at $2,750 per ounce, with All-In Sustaining Costs (“AISC”) that allow for profitability with an after-tax IRR of 65% and a rapid payback period of 1.8 years. Given that gold has been trading mostly between $4,500 and $5,500 per ounce during the past three months, Ténière said recent market fluctuations have not been a concern. “With this being such a low-cost operation, we don’t anticipate any issues there at all,” he said.

LaFleur is aiming to restart the Beacon Gold Mill this spring, to capitalize on the robust price of gold. The mill was formerly owned by Monarch Mining, who refurbished the mill for about $20 million in 2022, Malhi said. LaFleur obtained the mill and the Swanson deposit at a bankruptcy sale two years ago and is nearing the finish line on its efforts to resume operations at the site, which would be a major pivot point for the company as it enters revenue generation.

“The Beacon Gold Mill is fully permitted, refurbished, and funded for restart following a C$7 million financing,” recent analysis by Zacks Small Cap Research states (https://nnw.fm/nrxNe ). “With multiple catalysts ahead, including ongoing drill results, bulk sample approval, and mill commissioning, the company is positioned for a meaningful re-rating as it advances toward production.”

Malhi said the company plans a new capital raise in April or May. The executives noted that the mill’s current processing capacity is around 750 metric tons of material per day, but after LaFleur meets its initial target of restarting the mill with a gold pour from a Swanson bulk sample, the company aims to upgrade the mill to 3,000 to 4,000 tonnes per day, which would put it in the category of about 100,000 ounces per year.

The mill “is able to process gold, silver, and even a little bit of base metals as well, so it can handle multi-element-type deposits,” Ténière said during a separate event last month (https://nnw.fm/WOU6a ).

The initial Swanson Deposit obtained from Monarch was “fairly small” — 6,000 hectares (14,826 acres), Malhi said. But LaFleur continued to increase its exploration potential, obtaining additional area from Abcourt Mines and Globex Mining to position its project size at about 19,214 hectares (47,479 acres) currently. “We did that by incorporating other known deposits within the area, and especially to the south,” Ténière said. “Our goal is to continue to increase the size of the resource. Not just at the Swanson Deposit but across the entire project area.”

There are two major structures running through the project and Ténière said, “We have over 50 showings in some cases including for gold, for base metals.”

A recording of the webinar will be placed on the company’s website.

For more information, visit the company’s website at LaFleurMinerals.com.

NOTE TO INVESTORS: The latest news and updates relating to LFLRF are available in the company’s newsroom at https://nnw.fm/LFLRF

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer

LaFleur Minerals Inc. (LFLRF) Stock Research Links

LFLRF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 220

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 0

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 90

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 228

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 408

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 39

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 164

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 208

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 237

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

SoftBank Expands AI Infrastructure with DigitalBridge Deal

Updated Category News Views 109

SoftBank's Strategic Move in AI Infrastructure SoftBank Group Corp. has recently announced its plans to acquire DigitalBridge Group Inc. in a cash deal worth approximately $4 billion. This move is seen as a pivotal step in SoftBank's commitment to scaling its infrastructure capabilities for artificial intelligence globally. Details of the Acquisition Under the terms of...

Continue Reading
Nio's Bold Moves in the EV Space: What Investors Should Know

Updated Category News Views 158

Forget the Noise, Nio's Got a Game Plan Back in my day, when you heard whispers about a new product launch, it was either a cause for celebration or a catastrophe waiting to happen. Nio, the fast-rising EV player from China, is set to drop its ES9 SUV this May, and trust me, eyes are on the road. They’ve laid out the details like a clear roadmap. Mark Your Calendars Qin...

Continue Reading
Graycliff Partners Declares Landmark Structures Sale to Cerberus

Updated Category News Views 166

Graycliff Partners Announces the Sale of Landmark Structures Graycliff Partners LP has revealed its decision to sell Landmark Structures, an esteemed provider of water and industrial storage infrastructure solutions, to Cerberus Capital Management, a robust investment firm with a global reach. Landmark Structures specializes in designing, manufacturing, and installing...

Continue Reading
Wedbush Recognizes Uber Technologies as a Top Investment

Updated Category News Views 229

Wedbush Identifies Uber Technologies as a Prime Investment Opportunity In a recent analysis, Wedbush has included Uber Technologies Inc (NYSE: UBER) in its prestigious 'best ideas list.' This recognition stems from the company's attractive risk/reward dynamics, particularly as its shares are trading at a lower multiple. Valuation Insights Currently, Uber's stock is...

Continue Reading
Ververica Enhances Global Impact Through Innovative Partnerships

Updated Category News Views 161

Ververica's Global Influence in Real-Time Data Streaming Ververica, the pioneers behind Apache Flink®, recently highlighted its expanding global impact during the Flink Forward Jakarta event. This flagship occasion, known for focusing on cutting-edge data streaming technologies, served as an excellent platform for Ververica to demonstrate its dedication to helping...

Continue Reading